Back to Journals » International Journal of Nanomedicine » Volume 10 » Issue 1

Functional consequences for primary human alveolar macrophages following treatment with long, but not short, multiwalled carbon nanotubes

Authors Sweeney S, Grandolfo D, Ruenraroengsak P, Tetley T

Received 21 November 2014

Accepted for publication 5 February 2015

Published 23 April 2015 Volume 2015:10(1) Pages 3115—3129

DOI https://doi.org/10.2147/IJN.S77867

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Dr Thomas J Webster

Sinbad Sweeney, Davide Grandolfo, Pakatip Ruenraroengsak, Teresa D Tetley

Lung Cell Biology, Section of Pharmacology and Toxicology, National Heart and Lung Institute, Imperial College London, London, UK

Purpose: Multiwalled carbon nanotubes (MWCNTs) are a potential human health hazard, primarily via inhalation. In the lung, alveolar macrophages (AMs) provide the first line of immune cellular defense against inhaled materials. We hypothesized that, 1 and 5 days after treating AMs with short (0.6 µm in length; MWCNT-0.6 µm) and long (20 µm in length; MWCNT-20 µm) MWCNTs for 24 hours, AMs would exhibit increased markers of adverse bioreactivity (cytokine release and reactive oxygen species generation) while also having a modified functional ability (phagocytosis and migration).
Methods: Primary human AMs were treated with short and long MWCNTs for 24 hours, 1 and 5 days after which toxicity end points, including cell death, reactive oxygen species generation, and inflammatory mediator release, were measured. AM functional end points involving phagocytic ability and migratory capacity were also measured.
Results: AM viability was significantly decreased at 1 and 5 days after treatment with MWCNT-20 µm, while superoxide levels and inflammatory mediator release were significantly increased. At the same time, there was reduced phagocytosis and migratory capacity alongside increased expression of MARCO; this coincided with frustrated phagocytosis observed by scanning electron microscopy. In contrast, the adverse bioreactivity of the shorter MWCNT-0.6 µm with AMs (and any resulting reduction in AM functional ability) was substantially less marked or absent altogether.
Conclusion: This study shows that after 24-hour treatment with long, but not short, MWCNTs, AM function is severely affected up to 5 days after the initial exposure. This has potentially significant pathophysiological consequences for individuals who may be intentionally (via therapeutic applications) or unintentionally exposed to these nanomaterials.

Keywords: nanotechnology, MWCNTs, alveolar macrophages, cytokines, phagocytosis, bioreactivity

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under a Creative Commons Attribution License. The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/. The license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy

Tseng SH, Chou MY, Chu IM

International Journal of Nanomedicine 2015, 10:3663-3685

Published Date: 20 May 2015

Electrospun nanofibrous SF/P(LLA-CL) membrane: a potential substratum for endothelial keratoplasty

Chen JZ, Yan CX, Zhu MY, Yao QK, Shao CY, Lu WJ, Wang J, Mo XM, Gu P, Fu Y, Fan XQ

International Journal of Nanomedicine 2015, 10:3337-3350

Published Date: 5 May 2015

Functionalized magnetic iron oxide/alginate core-shell nanoparticles for targeting hyperthermia

Liao SH, Liu CH, Bastakoti BP, Suzuki N, Chang Y, Yamauchi Y, Lin FH, Wu KCW

International Journal of Nanomedicine 2015, 10:3315-3328

Published Date: 4 May 2015

Characterization of nanostructured ureteral stent with gradient degradation in a porcine model

Wang XQ, Shan HL, Wang JX, Hou YC, Ding JX, Chen QH, Guan JJ, Wang CX, Chen XS

International Journal of Nanomedicine 2015, 10:3055-3064

Published Date: 20 April 2015

Pharmacokinetics of quercetin-loaded nanodroplets with ultrasound activation and their use for bioimaging

Chang LW, Hou ML, Hung SH, Lin LC, Tsai TH

International Journal of Nanomedicine 2015, 10:3031-3042

Published Date: 17 April 2015

Fluoromica nanoparticle cytotoxicity in macrophages decreases with size and extent of uptake

Tee N, Zhu Y, Mortimer GM, Martin DJ, Minchin RF

International Journal of Nanomedicine 2015, 10:2363-2375

Published Date: 26 March 2015

Folate-modified lipid–polymer hybrid nanoparticles for targeted paclitaxel delivery

Zhang L, Zhu D, Dong X, Sun H, Song C, Wang C, Kong D

International Journal of Nanomedicine 2015, 10:2101-2114

Published Date: 16 March 2015